Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 15:12:09003.
doi: 10.7189/jogh.12.09003. eCollection 2022.

Research priorities to reduce the impact of COVID-19 in low- and middle-income countries

Ozren Polašek  1   2   3 Kerri Wazny  4 Davies Adeloye  5 Peige Song  6 Kit Y Chan  5 Danladi A Bojude  7 Sajjad Ali  8 Sheri Bastien  9 Francisco Becerra-Posada  10 Florencia Borrescio-Higa  11 Sohaila Cheema  12 Darien A Cipta  13 Smiljana Cvjetković  14 Lina D Castro  15 Bassey Ebenso  16 Omolade Femi-Ajao  17 Balasankar Ganesan  18 Anton Glasnović  19 Longtao He  20 Jean M Heraud  21 Chinonso Igwesi-Chidobe  22 Per O Iversen  23 Bismeen Jadoon  24 Abdulkarim J Karim  25 Johra Khan  26 Raaj K Biswas  27 Giuseppe Lanza  28   29 Shaun Wh Lee  30 You Li  31 Li-Lin Liang  32 Mat Lowe  33 Mohammad M Islam  34 Ana Marušić  35 Suleiman Mshelia  36 Anthony M Manyara  37 Mila Nn Htay  38 Michelle Parisi  39 Prince Peprah  40 Emma Sacks  41 Kabiru O Akinyemi  42 Fariba Shahraki-Sanavi  43 Konstantin Sharov  44 Elena S Rotarou  45 Srdjan Stankov  46 Wenang Supriyatiningsih  47 Benjamin Ty Chan  48 Mark Tremblay  49 Dialechti Tsimpida  17 Sandro Vento  50 Josipa V Glasnović  51 Liang Wang  52 Xin Wang  31 Zhi X Ng  53 Jianrong Zhang  54 Yanfeng Zhang  55 Harry Campbell  5 Mickey Chopra  56 Simon Cousens  57 Goran Krstić  58 Calum Macdonald  5 Parisa Mansoori  59 Smruti Patel  60 Aziz Sheikh  61 Mark Tomlinson  62 Alexander C Tsai  63 Sachiyo Yoshida  64 Igor Rudan  5
Affiliations

Research priorities to reduce the impact of COVID-19 in low- and middle-income countries

Ozren Polašek et al. J Glob Health. .

Abstract

Background: The COVID-19 pandemic has caused disruptions to the functioning of societies and their health systems. Prior to the pandemic, health systems in low- and middle-income countries (LMIC) were particularly stretched and vulnerable. The International Society of Global Health (ISoGH) sought to systematically identify priorities for health research that would have the potential to reduce the impact of the COVID-19 pandemic in LMICs.

Methods: The Child Health and Nutrition Research Initiative (CHNRI) method was used to identify COVID-19-related research priorities. All ISoGH members were invited to participate. Seventy-nine experts in clinical, translational, and population research contributed 192 research questions for consideration. Fifty-two experts then scored those questions based on five pre-defined criteria that were selected for this exercise: 1) feasibility and answerability; 2) potential for burden reduction; 3) potential for a paradigm shift; 4) potential for translation and implementation; and 5) impact on equity.

Results: Among the top 10 research priorities, research questions related to vaccination were prominent: health care system access barriers to equitable uptake of COVID-19 vaccination (ranked 1st), determinants of vaccine hesitancy (4th), development and evaluation of effective interventions to decrease vaccine hesitancy (5th), and vaccination impacts on vulnerable population/s (6th). Health care delivery questions also ranked highly, including: effective strategies to manage COVID-19 globally and in LMICs (2nd) and integrating health care for COVID-19 with other essential health services in LMICs (3rd). Additionally, the assessment of COVID-19 patients' needs in rural areas of LMICs was ranked 7th, and studying the leading socioeconomic determinants and consequences of the COVID-19 pandemic in LMICs using multi-faceted approaches was ranked 8th. The remaining questions in the top 10 were: clarifying paediatric case-fatality rates (CFR) in LMICs and identifying effective strategies for community engagement against COVID-19 in different LMIC contexts.

Interpretation: Health policy and systems research to inform COVID-19 vaccine uptake and equitable access to care are urgently needed, especially for rural, vulnerable, and/or marginalised populations. This research should occur in parallel with studies that will identify approaches to minimise vaccine hesitancy and effectively integrate care for COVID-19 with other essential health services in LMICs. ISoGH calls on the funders of health research in LMICs to consider the urgency and priority of this research during the COVID-19 pandemic and support studies that could make a positive difference for the populations of LMICs.

PubMed Disclaimer

Conflict of interest statement

Competing interests: Ana Marušić, Harry Campbell and Igor Rudan are the Co-Editors in Chief of the Journal of Global Health. To ensure that any possible conflict of interest relevant to the journal has been addressed, this article was reviewed according to best practice guidelines of international editorial organisations. The authors completed the ICMJE Unified Competing Interests Form (available upon request from the corresponding author) and declare no further conflicts of interest.

References

    1. Yoshida S.Approaches, tools and methods used for setting priorities in health research in the 21(st) century. J Glob Health. 2016;6:010507. - PMC - PubMed
    1. National Library of Medicine PubMed. Available: https://pubmed.ncbi.nlm.nih.gov/?term=sars-cov-2+OR+COVID-19&sort=date. Accessed: 30 January 2022.
    1. The World Health Organization. A coordinated global research roadmap: 2019 novel Coronavirus. Geneva: WHO; 2020.
    1. Sisa I, Fornasini M, Teran E.COVID-19 research in LMICs. Lancet. 2021;398:1212-3. 10.1016/S0140-6736(21)01605-6 - DOI - PMC - PubMed
    1. Antonio E, Alobo M, Tufet Bayona M, Marsh K, Norton A.Funding and COVID-19 research priorities - are the research needs for Africa being met? AAS Open Res. 2020;3:56. 10.12688/aasopenres.13162.1 - DOI - PMC - PubMed

Substances